keyword
MENU ▼
Read by QxMD icon Read
search

Transitional bladder cancer

keyword
https://www.readbyqxmd.com/read/29772237/lsinct5-activates-wnt-%C3%AE-catenin-signaling-by-interacting-with-ncym-to-promote-bladder-cancer-progression
#1
Xiaobo Zhu, Yuqiao Li, Shikai Zhao, Shouguo Zhao
Accumulating evidence has indicated that long non-coding RNAs (lncRNAs) are critically involved in tumor progression. In current study, we reported a novel lncRNA signature correlated with bladder cancer development. Particularly, the lncRNA long stress-induced noncoding transcript 5 (LSINCT5) is significantly upregulated in human bladder cancer cell lines and tumor specimens. Meanwhile, high LSINCT5 expression correlates with poor prognosis, enhances tumor sphere formation and invasion in vitro. In vivo xenograft tumor growth is also elevated by LSINCT5 overexpression...
May 14, 2018: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/29753463/de-novo-urologic-malignancies-in-renal-transplant-recipients
#2
H Antunes, E Tavares-da-Silva, R Oliveira, J Carvalho, B Parada, C Bastos, A Figueiredo
BACKGROUND: Immunosuppressed organ transplant patients have an elevated risk of malignancies. The aim of this study was to determine the incidence of urologic malignancies in renal transplant recipients, as well as to evaluate their monitoring, treatment, and outcomes. METHODS: We conducted a retrospective single-center study of 2897 renal transplants between January 1987 and December 2016. Recipients presenting with de novo urologic malignancies were evaluated...
March 10, 2018: Transplantation Proceedings
https://www.readbyqxmd.com/read/29749526/human-hla%C3%A2-f-adjacent-transcript-10-promotes-the-formation-of-cancer-initiating-cells-and-cisplatin-resistance-in-bladder-cancer
#3
Chen Li, Zhenfan Wang, Ninghan Feng, Jian Dong, Xiaoyan Deng, Yin Yue, Yuehong Guo, Jianquan Hou
Epithelial to mesenchymal transition (EMT) serves important roles in tumor invasion, metastasis, formation of cancer initiating cells (CICs) and drug resistance. HLA‑F adjacent transcript 10 (FAT10) has been proposed as an oncogene in bladder cancer. However, the functional contribution of FAT10 to EMT and the formation of CICs remains unclear in bladder cancer. The present study reports that FAT10 protein expression is upregulated in bladder cancer cell lines, and the overexpression of FAT10 promotes EMT and the formation of CICs in bladder cancer UMUC‑3 cells...
May 9, 2018: Molecular Medicine Reports
https://www.readbyqxmd.com/read/29747777/mir-429-expression-in-bladder-cancer-and-its-correlation-with-tumor-behavior-and-clinical-outcome
#4
Chia-Lun Wu, Jar-Yi Ho, Shun-Hsing Hung, Dah-Shyong Yu
We previously showed that microRNA-429 (miR-429) played an important role in epithelial-mesenchymal transition (EMT) of urothelial cell carcinoma of the bladder. We herein evaluated the expression of miR-429 in bladder cancer and its potential relevance to clinicopathological characteristics and patient survival. Relative expression levels of miR-429 in surgical bladder cancer tissue specimens obtained from 76 patients with bladder cancer were measured by chromogenic in situ hybridization. miR-429 expression was significantly higher in specimens from alive patients than expired patients in both of 5-year overall survival (OS) (0...
June 2018: Kaohsiung Journal of Medical Sciences
https://www.readbyqxmd.com/read/29745925/-mechanism-of-action-of-intravesical-bcg-biological-bases-and-clinical-applicability
#5
Joaquín A Carballido, María Rodríguez Monsalve
The therapeutic approaches developed around immune system modulation find the therapeutic contribution of intravesical Bacillus Calmette Guerin (BCG) for transitional cell bladder cancer an unquestionable example as a proof of concept of antitumor immunotherapy since more than 30 years ago. Intravesical immunotherapy for urothelial carcinomas is considered with periodic intravesical instillations schedules, and the one with longer historic development and wider diffusion is BCG in the form of suspension. BCG is a unique strain obtained from Mycobacterium bovis at the end of the first third of the XX century and represents the historically most successful immunotherapeutic modality of all tumors with a high level body of evidence...
May 2018: Archivos Españoles de Urología
https://www.readbyqxmd.com/read/29741444/isoquercitrin-ingredients-in-tetrastigma-hemsleyanum-diels-et-gilg-inhibits-hepatocyte-growth-factor-scatter-factor-induced-tumor-cell-migration-and-invasion
#6
Geng-Shou Xia, Shu-Hong Li, Wu Zhou
Aberrant activation of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, Met, is involved in the development and progression of many human cancers. In the screening assay of extracts from the root tuber of Tetrastigma hemsleyanum Diels et Gilg, isoquercitrin inhibited HGF/SF-Met signaling as indicated by its inhibitory activity on HGF/SF-induced cell scattering. Further analysis revealed that isoquercitrin specifically inhibited HGF/SF-induced tyrosine phosphorylation of Met. We also found that isoquercitrin decreased HGF-induced migration and invasion by parental or HGF/SF-transfected bladder carcinoma cell line NBT-II cells...
May 9, 2018: Cell Adhesion & Migration
https://www.readbyqxmd.com/read/29739079/hsa-mir-3658-promotes-cell-proliferation-migration-and-invasion-by-effecting-lass2-in-bladder-cancer
#7
Ting Luan, Renchao Zou, Lijuan Huang, Ning Li, Shi Fu, Yinglong Huang, Haifeng Wang, Jiansong Wang
BACKGROUND: Hsa-miR-3658 is upregulated in various tumors, but its expression in bladder cancer has been rarely studied. METHODS: In this study, hsa-miR-3658 expressions in several bladder cancer cell lines were examined, and its effect on the malignant degree of bladder cancer and whether hsa-miR-3658 regulates tumor biological behaviors through LASS2 and its downstream molecular pathway were studied and validated. RESULTS: It was found miR-3658 expressions differed among different cell lines, which may be an influence factor on the malignancy...
April 1, 2018: Clinical Laboratory
https://www.readbyqxmd.com/read/29732388/systematic-review-characteristics-and-preclinical-uses-of-bladder-cancer-cell-lines
#8
Tahlita C M Zuiverloon, Florus C de Jong, James C Costello, Dan Theodorescu
Background: Bladder cancer (BC) cell lines are indispensable in basic and preclinical research. Currently, an up-to-date and comprehensive overview of available BC cell lines is not available. Objective: To provide an overview and resources on the origin, pathological and molecular characteristics of commonly used human, murine and canine BC cell lines. Methods: A PubMed search was performed for relevant articles published between 1980 and 2017 according to the following MeSH terms: cell line; cell line, tumor; urinary bladder neoplasms; carcinoma, transitional cell...
April 26, 2018: Bladder Cancer
https://www.readbyqxmd.com/read/29731962/gamma-klotho-exhibits-multiple-roles-in-tumor-growth-of-human-bladder-cancer
#9
Shunta Hori, Makito Miyake, Yoshihiro Tatsumi, Yosuke Morizawa, Yasushi Nakai, Sayuri Onishi, Kenta Onishi, Kota Iida, Daisuke Gotoh, Nobumichi Tanaka, Kiyohide Fujimoto
Alpha-Klotho (KLα) and beta-Klotho (KLβ) have recently been reported to correlate with cancer prognosis in some malignancies and we previously reported the association between KLα, KLβ, and urothelial carcinoma of the bladder (UCB), indicating that KLβ acts as a tumor promoter. However, the association between gamma-Klotho (KLγ) and cancer prognosis remains unclear. In the present study, we evaluated the association between KLγ and UCB. To evaluate the effect of KLγ on human bladder cancer cell lines in vitro assays were performed...
April 13, 2018: Oncotarget
https://www.readbyqxmd.com/read/29730950/emerging-intravesical-drugs-for-the-treatment-of-non-muscle-invasive-bladder-cancer
#10
Jasper Crijnen, Theo M de Reijke
Bladder cancer (BC) is a severe health burden: it is the fifth most common malignancy in the world and has high recurrence and progression rates. Standard treatment starts with TURB followed by intravesical chemotherapy with Mitomycin C or immunotherapy with BCG. However, successful management still remains a challenge, because approximately 30% of patients have recurrence or progression within 5 years, and treatment has considerable side effects. Anticipating on the upcoming BCG shortage emphasizes, moreover, the necessity to develop and study novel treatments...
May 5, 2018: Expert Opinion on Emerging Drugs
https://www.readbyqxmd.com/read/29721181/near-infrared-photoimmunotherapy-targeting-bladder-cancer-with-a-canine-anti-epidermal-growth-factor-receptor-egfr-antibody
#11
Tadanobu Nagaya, Shuhei Okuyama, Fusa Ogata, Yasuhiro Maruoka, Deborah W Knapp, Sophia N Karagiannis, Judit Fazekas-Singer, Peter L Choyke, Amy K LeBlanc, Erika Jensen-Jarolim, Hisataka Kobayashi
Anti-epidermal growth factor receptor (EGFR) antibody therapy is used in EGFR expressing cancers including lung, colon, head and neck, and bladder cancers, however results have been modest. Near infrared photoimmunotherapy (NIR-PIT) is a highly selective tumor treatment that employs an antibody-photo-absorber conjugate which is activated by NIR light. NIR-PIT is in clinical trials in patients with recurrent head and neck cancers using cetuximab-IR700 as the conjugate. However, its use has otherwise been restricted to mouse models...
April 10, 2018: Oncotarget
https://www.readbyqxmd.com/read/29719304/prognostic-value-of-soluble-death-receptor-ligands-in-patients-with-transitional-cell-carcinoma-of-bladder
#12
Islem Ben Bahria-Sediki, Mohamed Chebil, Carla Sampaio, Véronique Martel-Frachet, Mohamed Cherif, Rachida Zermani, Soumaya Rammeh, Amel Ben Ammar Gaaied, Ali Bettaieb
BACKGROUND: The activation of Fas/Fas ligand (FasL) and DR4-DR5/tumor necrosis factor-related-apoptosis-inducing ligand (TRAIL) pathways in cancer cells triggers apoptosis. The objective of this study was to investigate the prognostic value of soluble FasL (sFasL) and soluble (sTRAIL) in the serum of patients with bladder cancer. METHODS: The sFasL and sTRAIL levels in the sera of patients with bladder cancer or healthy donors were determined using the enzyme-linked immunosorbent assay...
May 2, 2018: Urologia Internationalis
https://www.readbyqxmd.com/read/29715095/the-immune-checkpoint-molecule-cd200-is-associated-with-tumor-grading-and-metastasis-in-bladder-cancer
#13
Peter Rexin, Alessa Tauchert, Jörg Hänze, Hendrik Heers, Ansgar Schmidt, Rainer Hofmann, Axel Hegele
BACKGROUND: We examined the expression of CD200, a ligand of immune tolerance, in transitional cell carcinoma of the human bladder (TCC). MATERIALS AND METHODS: CD200 was analyzed by immunohistochemistry (IHC) in 90 patients with suspected TCC lesions of the bladder. Expression of CD200 was exemplarily validated by quantitative reverse transcription polymerase chain reaction and western blot analysis. RESULTS: CD200 was detectable at mRNA and protein levels in TCC homogenate and TCC cell lines (T24, UMUC3)...
May 2018: Anticancer Research
https://www.readbyqxmd.com/read/29704582/robotic-single-port-partial-prostatectomy-for-anterior-tumors-transvesical-approach
#14
Jihad Kaouk, Juan Garisto, Daniel Sagalovich, Julien Dagenais, Riccardo Bertolo, Eric Klein
OBJECTIVES: To evaluate the feasibility of a single port transvesical robotic approach for anterior partial prostatectomy (SP-TVPP) in a cadaver model. METHODS: The cadavers were placed in a lithothomy position and secured to the operating table. A 3-cm midline incision was made in the suprapubic skin fold. After opening the Retzius space, a single-port mini device (GelPOINT, Rancho Margarita, California, USA) was introduced percutaneously directly into the bladder...
April 25, 2018: Urology
https://www.readbyqxmd.com/read/29678595/trimodalities-for-bladder-cancer-in-elderly-transurethral-resection-hypofractionated-radiotherapy-and-gemcitabine
#15
H A H Mohamed, M A Salem, M S Elnaggar, A Gabr, A M Abdelrheem
PURPOSE: A prospective phase II study carried out to evaluate hypofractionated radiotherapy with concurrent gemcitabine for bladder preservation in the elderly patient with bladder cancer. PATIENTS AND METHODS: Thirty-one patients were enrolled, age ≥65years, diagnosed with transitional cell carcinoma of the urinary bladder, after a maximum safe transurethral resection of a bladder tumour. They received 52.5Gy in 20 fractions using 3D conformal radiotherapy with concurrent 100mg/m2 gemcitabine weekly as a radiosensitizer...
April 17, 2018: Cancer Radiothérapie: Journal de la Société Française de Radiothérapie Oncologique
https://www.readbyqxmd.com/read/29650141/adjuvant-therapy-in-muscle-invasive-bladder-cancer-and-upper-tract-urothelial-carcinoma
#16
REVIEW
Tala Achkar, Rahul A Parikh
This article summarizes the role of adjuvant chemotherapy in muscle-invasive and transitional cell carcinoma of the bladder and upper urinary tract.
May 2018: Urologic Clinics of North America
https://www.readbyqxmd.com/read/29643727/outcome-of-mainz-ii-pouch-urinary-diversion-after-radical-cystectomy-in-patients-with-muscle-invasive-bladder-cancer-our-experience
#17
Stephen Odunayo Ikuerowo, Olufemi O Ojewuyi, Muftau Jimoh Bioku, Abimbola Ayodeji Abolarinwa, Olufunmilade Akinfolarin Omisanjo
Introduction: Mainz II pouch urinary diversion in patients with muscle-invasive bladder cancer is one of the options of continent urinary diversion following radical cystectomy (RC). We aim to report our experience and the outcome of our patients who had this procedure. Patients and Methods: Patients who had RC and Mainz II pouch urinary diversion for muscle-invasive bladder cancer in our institution from 2007 to 2016 were evaluated. Variables analyzed included age, gender, stage of the disease, pathological grade and tumor types, complications, and survival status...
January 2018: Nigerian Journal of Surgery: Official Publication of the Nigerian Surgical Research Society
https://www.readbyqxmd.com/read/29643502/unravelling-disparate-roles-of-notch-in-bladder-cancer
#18
REVIEW
Akihiro Goriki, Roland Seiler, Alexander W Wyatt, Alberto Contreras-Sanz, Akshay Bhat, Akio Matsubara, Tetsutaro Hayashi, Peter C Black
The Notch pathway has been implicated in both oncogenic and tumour-suppressive roles in cancer depending on the tissue type and cellular context. However, until recently, little was known about the pathway in bladder cancer. Studies have revealed that NOTCH1 copy number and expression are decreased in bladder cancer and NOTCH1 activation in bladder cancer cell lines reduces proliferation, suggesting that NOTCH1 acts as a tumour suppressor. Furthermore, in transgenic models, bladder cancer is promoted by bladder-specific inactivation of a component of the γ-secretase complex, which liberates the intracellular domain of neurogenic locus Notch homologue protein (NOTCH) and starts the signalling cascade...
April 11, 2018: Nature Reviews. Urology
https://www.readbyqxmd.com/read/29625110/lncrna-tp73-as1-predicts-the-prognosis-of-bladder-cancer-patients-and-functions-as-a-suppressor-for-bladder-cancer-by-emt-pathway
#19
Zhiyong Tuo, Jianbin Zhang, Wei Xue
Long noncoding RNAs (lncRNAs) have been identified to have more and more important roles in tumorigenesis and may be novel biomarker for cancer therapy. LncRNA TP73-AS1 is a novel identified lncRNA that has been demonstrated to be increased in several cancers, however, its function in bladder cancer remains unknown. The aim of this work was to examine the expression and role of lncRNA TP73-AS1 in bladder cancer. The expression levels of lncRNA TP73-AS1 in bladder cancer tissues and cell lines were determined by quantitative real-time PCR (qRT-PCR), and its clinical significance was assessed by statistical analysis...
May 23, 2018: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/29620192/tumor-suppressing-effects-of-microrna-612-in-bladder-cancer-cells-by-targeting-malic-enzyme-1-expression
#20
Mengnan Liu, Yifan Chen, Bisheng Huang, Shiyu Mao, Keke Cai, Longsheng Wang, Xudong Yao
The present study investigated the possible tumor-suppressing function of microRNA (miR)-612 and the underlying molecular mechanism of its action in bladder cancer in vitro and in vivo. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was carried out to quantify the expression levels of miR‑612 in bladder cancer tissues and cell lines. The data demonstrated that the level of miR‑612 expression was significantly reduced in bladder cancer tissues and cell lines, as compared with that in non‑cancerous tissues and cells...
March 29, 2018: International Journal of Oncology
keyword
keyword
92895
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"